Health CarePharmaceuticals & Biotechnology
  • Price (CHF)345.80
  • Today's Change-0.300 / -0.09%
  • Shares traded624.12k
  • 1 Year change8.50%
  • Beta1.1826
Data delayed at least 15 minutes, as of Sep 20 2019 16:31 BST.
More ▼

Events & Activity

  • LONN:VTX price rises above 50-day moving average to 343.70 at 10:00 BST
  • LONN:VTX price rises above 50-day moving average to 342.90 at 18:31 BST
  • LONN:VTX price moved over -1.01% to 334.80
  • LONN:VTX price rises above 15-day moving average to 350.20 at 10:00 BST

Key statistics

On Friday, Lonza Group AG (LONN:VTX) closed at 345.80, -5.00% below its 52-week high of 364.00, set on Sep 04, 2019.
52-week range
245.10Dec 27 2018364.00Sep 04 2019
Markit short selling activity
Previous close346.10
Average volume477.74k
Shares outstanding74.47m
Free float74.46m
P/E (TTM)39.71
Market cap25.54bn CHF
EPS (TTM)8.64
Annual div (ADY)2.75
Annual div yield (ADY)0.79%
Div ex-dateApr 24 2019
Div pay-dateApr 26 2019
Data delayed at least 15 minutes, as of Sep 20 2019 16:31 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.